布里拉西丁作为包裹,急性传染性病毒的宽谱抑制剂
Carol A Anderson1, Michael D Barrera1, Niloufar A Boghdeh1
1Center for Infectious Disease Research, School of Systems Biology, George Mason University, Manassas, VA 20110, USA.
Microorganisms
|January 23, 2024
概括
布里拉西丁对阿尔法病毒和布尼亚病毒具有抗病毒活性,包括委内瑞拉马类脑炎病毒 (VEEV) 和裂谷热病毒 (RVFV). 它的有效性取决于剂量的时间,对非包裹的Echovirus具有适度的活性.
科学领域:
- 病毒学和传染病学.
- 药物的发现和开发.
- 宿主-病原体相互作用
背景情况:
- 阿尔法病毒和布尼亚病毒是重要的全球病原体,缺乏经批准的治疗方法.
- 委内瑞拉马脑炎病毒 (VEEV),东部马脑炎病毒 (EEEV),Sindbis病毒 (SINV) 和裂谷热病毒 (RVFV) 导致人类严重疾病.
- 迫切需要针对这些新兴病毒威胁的新疗法.
研究的目的:
- 评估新型小分子布里拉西丁对临床相关的α病毒和bunyavirus的抗病毒潜力.
- 通过测试它对埃科病毒 (一种非包裹病毒) 的有效性来研究布里拉西丁的作用机制.
- 为了确定布里拉西丁抗病毒作用的最佳剂量策略.
主要方法:
- 布里拉西丁的抗病毒活性在人类小气道上皮细胞 (HSAEC) 和非洲绿子脏细胞 (Veros) 中进行了评估.
- 对VEEV,EEEV,SINV,RVFV和Echovirus进行病毒载荷抑制测量.
- 剂量策略包括感染前和感染后的化合物添加,以评估时间依赖的疗效.
主要成果:
- 布里拉西丁对VEEV,EEEV,SINV和RVFV表现出显著的抗病毒活性.
- 最佳的抑制需要在病毒感染之前和之后给予布里拉西丁.
- 该化合物对非包裹的埃科病毒仅表现出适度的抑制作用.
结论:
- 布里拉西丁是治疗alphavirus和bunyavirus感染的有希望的候选药物.
- 布里拉西丁的疗效取决于相对于感染的治疗时间.
- 布里拉西丁可能对包裹病毒比埃科病毒等非包裹病毒更有效.
相关概念视频
Viruses of Archaea
Archaeal viruses play a crucial role in the ecosystems of extremophilic archaea, particularly those belonging to the phyla Euryarchaeota and Crenarchaeota. By shaping host evolution and facilitating gene transfer, these viruses influence microbial communities and contribute to genetic diversity in extreme environments. The archaea they infect thrive in acidic hot springs and hydrothermal vents characterized by high temperatures and low pH. Archaeal viruses exhibit remarkable structural...
The Antiviral System of Bacteria and Archaea: CRISPR
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this defense.
Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...


